Efficacy News and Research

RSS

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

25 Jun 2018

AbbVie and Calibr collaborate to develop T-cell therapies aimed at cancer

AbbVie , a research-based global biopharmaceutical company, and Calibr, a nonprofit drug discovery division of Scripps Research, today announced a collaboration to develop T-cell therapies aimed primarily at cancer, including solid tumors.

25 Jun 2018

New review outlines current state of sex-sensitive issues linked to heart failure drugs

Heart failure is almost as common in women as men, but its characteristics vary by sex.

22 Jun 2018

Study provides clues to how cancer cells develop resistance to chemotherapies

About half of all drugs, ranging from morphine to penicillin, come from compounds that are from - or have been derived from - nature. This includes many cancer drugs, which are toxic enough to kill cancer cells.

22 Jun 2018

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

A new study by iData Research estimates that there are nearly 150,000 new cases of psoriasis every year in the United States, affecting 2.2% of the population.

20 Jun 2018

New study is testing safety and efficacy of glycoside in breaking up kidney stones

For anyone who has suffered from kidney stones, the painful condition is not easily treatable, and patients are typically prescribed strong pain medication and fluids to alleviate symptoms.

20 Jun 2018

Study: Long-term estrogen therapy alters microbial composition and activity in the gut

Long-term therapy with estrogen and bazedoxifene alters the microbial composition and activity in the gut, affecting how estrogen is metabolized, a new study in mice found.

20 Jun 2018

Persistent psychological stress contributes to development and progression of vision loss

Persistent psychological stress, which is widely recognized as a consequence of vision loss, is also a major contributor to its development and progression, according to a study now published in the EPMA Journal, the official journal of the European Association for Predictive, Preventive, and Personalized Medicine.

19 Jun 2018

Combining two anti-malarial vaccines could greatly reduce number of infections

Using two experimental anti-malarial vaccines, which work in different ways, can greatly reduce the number of malaria infections in animal studies.

19 Jun 2018

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

SetPoint Medical, a clinical-stage biomedical technology company developing bioelectronic therapy for chronic inflammatory diseases, announced positive long-term data for its first-in-human study using bioelectronic medicine for rheumatoid arthritis

19 Jun 2018

Scientists develop novel computational framework to support personalized cancer treatment

Researchers at Columbia University Irving Medical Center have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug combinations that are most likely to kill them.

19 Jun 2018

WVU researcher aims to produce updated whooping cough vaccine

Before the whooping-cough vaccine came into widespread use in the 1940s, about 9,000 American children died from the infection each year. Today, thanks to the vaccine's efficacy, reported cases of whooping cough have dramatically declined and fatalities have dropped to up to 20 children each year.

18 Jun 2018

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

Bioverativ Inc., a Sanofi company dedicated to transforming the lives of people with rare blood disorders, today announced results from a new, population-based retrospective study that found a greater than twofold increased risk of mortality in people with cold agglutinin disease within the first five years after diagnosis.

18 Jun 2018

New simulation approach predicts efficacy of HIV-prophylaxis medications

A new mathematical simulation approach predicts the efficacy of pre- and post-exposure prophylaxis (PrEP) medications, which help prevent HIV infection. The framework, presented in PLOS Computational Biology by Sulav Duwal and Max von Kleist of Freie Universität Berlin and colleagues, could help streamline development of new PrEP treatments.

18 Jun 2018

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

The results of an open label extension of a phase II study presented today at the Annual European Congress of Rheumatology, 2018, demonstrate that lenabasum continues to have acceptable safety and tolerability in diffuse cutaneous systemic sclerosis with no severe or serious adverse events.

18 Jun 2018

Efficacy News and Research

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

AbbVie and Calibr collaborate to develop T-cell therapies aimed at cancer

New review outlines current state of sex-sensitive issues linked to heart failure drugs

Study provides clues to how cancer cells develop resistance to chemotherapies

Biosimilar competition may offer hope for cheaper, better psoriasis treatments in the future

New study is testing safety and efficacy of glycoside in breaking up kidney stones

Study: Long-term estrogen therapy alters microbial composition and activity in the gut

Persistent psychological stress contributes to development and progression of vision loss

Combining two anti-malarial vaccines could greatly reduce number of infections

SetPoint announces positive long-term results of bioelectronic medicine to treat rheumatoid arthritis

Scientists develop novel computational framework to support personalized cancer treatment

WVU researcher aims to produce updated whooping cough vaccine

Study finds increased risk of mortality in people with cold agglutinin disease in five years after diagnosis

New simulation approach predicts efficacy of HIV-prophylaxis medications

Study: Lenabasum has acceptable safety and tolerability in diffuse cutaneous systemic sclerosis

Canakinumab reduces gout rate by more than half in atherosclerosis patients, study shows

New clinical trial of MS drug will be first to recognize needs of wheelchair users

Combination of NSAIDs and TNF inhibitors linked to reduced radiographic progression in AS patients

Researchers show feasibility of stem cell-derived organoids for developing gene therapy vectors

Music therapy shows promise for improving lives of people with sickle cell disease

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News